Related Experiment Video
Updated: Jun 28, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Peptidoglycan from Lactiplantibacillus plantarum YC Alleviates Hyperuricemia via the "Microbiota-Gut-Kidney" Axis:
Yongshuai Liu1, Yiheng Zhang1, Jie Zheng1
1State Key Laboratory of Food Nutrition and Safety, College of Food Science and Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.
Abstract:
Hyperuricemia (HUA) is a prevalent metabolic disorder necessitating safe and effective interventions. Although probiotics demonstrate potential in HUA management, the specific contributions of their cellular components remain unexplored. In this study, peptidoglycan (PGN) isolated from Lactiplantibacillus plantarum YC was characterized as an A1γ-type chemotype (l-Ala-d-iGln-mDAP-d-Ala) via amino acid analysis, FTIR, NMR, and MALDI-TOF MS. In HUA mice, oral PGN significantly reduced serum uric acid, creatinine, and blood urea nitrogen levels. Mechanistically, PGN inhibited hepatic xanthine oxidase activity and transcriptionally remodeled the urate transport machinery by upregulating renal ABCG2/OAT1 and colonic ABCG2 expression, while downregulating renal URAT1/GLUT9 and colonic GLUT9 expression. Furthermore, PGN attenuated systemic inflammation by lowering TNF-α, IL-1β, and IL-6. Integrative multiomics revealed that PGN remodeled gut microbiota, notably enriching Muribaculaceae and Bacteroides, and modulated purine and amino acid metabolism. These findings identify L. plantarum YC-derived PGN as a promising postbiotic candidate for targeted HUA intervention via the microbiota-gut-kidney axis.
Related Concept Videos
Microbiota Modulation by Antibiotics
Gene Regulation in Microbial Communities: Quorum Sensing
Microbiota of the Urogenital Tract
Inhibitors of Gram-positive Cell Wall Synthesis
Peptidoglycan Synthesis
Probiotics
